Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.
Press releases published on April 30, 2025
AC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate Update
GlobeNewswire
·
April 30, 2025
AC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate Update Continuing to advance clinical active immunotherapy portfolio for precision prevention of neurodegenerative diseases Positive immunogenicity and good safety in interim …
Press Release: Sanofi and CD&R close Opella transaction, create global consumer healthcare leader
GlobeNewswire
·
April 30, 2025
Sanofi and CD…
Communiqué de presse : Sanofi et CD&R finalisent la cession d’Opella et créent un leader mondial de la santé grand public
GlobeNewswire
·
April 30, 2025
Sanofi et CD…
EyePoint to Report First Quarter 2025 Financial Results on May 7, 2025
GlobeNewswire
·
April 30, 2025
WATERTOWN, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today …
Avalo Therapeutics to Participate in The Citizens Life Sciences Conference
GlobeNewswire
·
April 30, 2025
WAYNE, Pa. and ROCKVILLE, Md., April 30, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company focused on the treatment of immune dysregulation, today announced that Dr. Garry Neil, Chief Executive Officer …
Veri Medtech (VRHI) Relaunches Veriheal.com
GlobeNewswire
·
April 30, 2025
NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- Veri Medtech (Stock Ticker Symbol: “VRHI”) announced today that it has relaunched its Veriheal.com healthcare technology platform. For more information, please visit: www.Veriheal.com. “Veri Medtech (VRHI) has …
Sionna Therapeutics to Present at The Citizens Life Sciences Conference 2025
GlobeNewswire
·
April 30, 2025
WALTHAM, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel medicines that …
10 Barrel Brewing Launches Non-Alcoholic Apocalypse IPA, a Bold Craft Brew for Your Next Adventure
GlobeNewswire
·
April 30, 2025
BEND, Ore., April 30, 2025 (GLOBE NEWSWIRE) -- 10 Barrel Brewing, a Tilray Brands, Inc., (NASDAQ: TLRY and TSX: TLRY) craft beer brand, is excited to announce the launch of NA Apocalypse IPA, a non-alcoholic version of their beloved Apocalypse IPA. This …
Nusano Names Rachel Culbertson VP of Supply Chain
GlobeNewswire
·
April 30, 2025
WEST VALLEY CITY, Utah, April 30, 2025 (GLOBE NEWSWIRE) -- Nusano, a physics company transforming the production of radioisotopes, today announced the appointment of Rachel Culbertson as Vice President of Supply Chain. Culbertson’s leadership will be …
ADMA Biologics to Report First Quarter 2025 Financial Results on May 7, 2025
GlobeNewswire
·
April 30, 2025
RAMSEY, N.J. and BOCA RATON, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), a U.S. based, end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing …
Akero Therapeutics Announces Upcoming Poster and Oral Presentations at the EASL Congress 2025
GlobeNewswire
·
April 30, 2025
SOUTH SAN FRANCISCO, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, today …
Larimar Therapeutics Reports First Quarter 2025 Financial Results
GlobeNewswire
·
April 30, 2025
FDA stated as part of a START pilot program meeting that it is open to considering skin FXN concentration as a reasonably likely surrogate endpoint in support of an accelerated approval BLA seeking accelerated approval planned to be submitted by year-end …
Eloro Resources Announces Restart of Definition Drilling Targeting Major Tin Discovery and High Grade Silver Zones at its Iska Iska Ag-Sn-Polymetallic Project, Potosi Department, Bolivia
GlobeNewswire
·
April 30, 2025
A new definition drill program comprised of 4,300m of diamond drilling in 8 holes that will commence shortly is focussed on upgrading and expanding high grade tin mineralization hosted in intrusion and phreatomagmatic breccia (TIB and TPMB, respectively) …
I-Mab Announces Givastomig Abstract Accepted for Oral Presentation at ESMO GI 2025
GlobeNewswire
·
April 30, 2025
ROCKVILLE, Md., April 30, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (the “Company”), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer, today announced that an abstract for …
XORTX Provides Update on FDA Type B Meeting Request
GlobeNewswire
·
April 30, 2025
● XORTX will focus on key steps to advance a NDA filing for Gout indication ● CALGARY, Alberta, April 30, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical …
Apellis Pharmaceuticals to Host Conference Call on May 7, 2025, to Discuss First Quarter 2025 Financial Results
GlobeNewswire
·
April 30, 2025
WALTHAM, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will host a conference call and webcast to discuss its first quarter 2025 financial results on Wednesday, May 7, 2025, at 8:30 …
OKYO Pharma Announces Plans to Accelerate the Clinical Development of Urcosimod to Treat Neuropathic Corneal Pain
GlobeNewswire
·
April 30, 2025
Urcosimod phase 2 trial treating Neuropathic Corneal Pain (“NCP”) patients was initiated in October 2024 and designed as a double-masked, randomized, 12-week placebo-controlled trial. OKYO Pharma plans to analyze the efficacy data from the 17 patients who …
CLIQ: Einladung zum Earnings Call für das erste Quartal 2025
GlobeNewswire
·
April 30, 2025
DÜSSELDORF, 30. April 2025 – Der CLIQ-Konzern wird am Donnerstag, den 8. Mai 2025, seine Finanzergebnisse und Highlights für das erste Quartal 2025 präsentieren. Der Finanzbericht Q1 2025 und die begleitende Präsentation zum Earnings Call werden ab 7:30 …
CLIQ: Invitation to First Quarter 2025 Results Presentation
GlobeNewswire
·
April 30, 2025
DÜSSELDORF, 30 April 2025 – The CLIQ Group will report and present its first quarter 2025 financial results and highlights on Thursday, 8 May 2025. The 1Q 2025 Financial Report and a slides deck to accompany the earnings call will be available at https:// …
Probe Gold Intersects 12.3 g/t Gold Over 20.7 Metres in Infill Drilling at Novador Project, Quebec
GlobeNewswire
·
April 30, 2025
Highlights: Monique Deposit (B …